ReviewEchocardiography (Mount Kisco, N.Y.)2026
The Emerging Role and Clinical Utility of Transnasal Transesophageal Echocardiography.
Review in Echocardiography (Mount Kisco, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Transesophageal echocardiography (TEE) is a cornerstone of cardiovascular diagnostics. A major advantage of TEE over transthoracic echo (TTE) is superior resolution of posterior structures such as the mitral valve and the left atrial appendage (LAA). TEE is invasive and requires the use of moderate and sometimes deeper levels of sedation. Anesthesia accounts for most TEE-related risks including hemodynamic (hypotension, arrythmia) and respiratory compromise. Risks of anesthesia are amplified by the high prevalence of co-morbidities in patients undergoing TEE. Anesthesia also requires specialized procedural space and skilled providers, limiting the availability of TEE, and increasing the overall cost of the procedure. Alternative TEE methods that minimize (or negate) the use of anesthesia would enhance workflow, expand availability, reduce risk, and may provide similar or more accurate information compared to conventional TEE. The nasal orifice is an alternative to the oral approach, and transnasal TEE can eliminate the need for anesthesia and expand availability of use, while minimizing risk of oropharyngeal injury. This review explores the emerging role of transnasal TEE as a viable alternative to the conventional oral approach and critically evaluates current technologies and clinical applications. Particular attention is given to unmet clinical needs, barriers to adoption, and future directions that may enable broader, safer, and more effective use of TEE in both procedural and non-procedural settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.